114 related articles for article (PubMed ID: 38182149)
1. Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway.
Wang L; Piao L; Yuan X; Tong L; Han X; Wang J; Shi D; Shao S; Xu X; Zhuang M; Cheng D; Liu Z
Ann Clin Lab Sci; 2023 Nov; 53(6):890-904. PubMed ID: 38182149
[TBL] [Abstract][Full Text] [Related]
2. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
4. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial-mesenchymal transition.
Wang X; Chen L; Huang K; Lin Y; Hong Y; Lin Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16473-16488. PubMed ID: 37712963
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
[TBL] [Abstract][Full Text] [Related]
6. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
7. Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer.
Zhu X; Xu X; Zhang L; Yang X
Thorac Cancer; 2023 Apr; 14(11):983-991. PubMed ID: 36825764
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.
Wu Z; Li S; Liu J; Shi Y; Wang J; Chen D; Luo L; Qian Y; Huang X; Wang H
Cancer Biol Ther; 2015; 16(9):1332-40. PubMed ID: 26176849
[TBL] [Abstract][Full Text] [Related]
9. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
11. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
12. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
[TBL] [Abstract][Full Text] [Related]
13. INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activation.
Zhang H; Huang Y; Wen Q; Li Y; Guo L; Ge N
J Orthop Surg Res; 2023 Nov; 18(1):848. PubMed ID: 37940978
[TBL] [Abstract][Full Text] [Related]
14. CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis.
Yang H; Liu X; Zhu X; Li X; Jiang L; Zhong M; Zhang M; Chen T; Ma M; Liang X; Lv K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784299
[TBL] [Abstract][Full Text] [Related]
15. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
16. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-
Shi Q; Wu H; Li Y; Shen L; Tian X; Lin T; Wei G
Biomed Res Int; 2020; 2020():8039840. PubMed ID: 33282954
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
Fu Y; Tang Y; Wang J; Guo Z
Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh1 regulates gastric cancer cell biological behaviours and transplanted tumour growth in nude mice via the TGF-β/Smad pathway.
Yang Z; Wu X; Shen J; Gudamu A; Ma Y; Zhang Z; Hou M
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1270-1280. PubMed ID: 36054718
[TBL] [Abstract][Full Text] [Related]
20. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.
Chen S; Luo Y; Cui L; Yang Q
Cell Cycle; 2020 Jul; 19(14):1740-1753. PubMed ID: 32635855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
